Performance analysis of Cytokinetics (CYTK)
Annual Return
Over the past 3 years, CYTK has had an average annual return of +22.35%, underperforming the benchmark SPY, which returned +22.45% annual.
Over the past 5 years, CYTK has had an average annual return of +28.25%, outperforming the benchmark SPY, which returned +13.88% annual.
Over the past 10 years, CYTK has had an average annual return of +24.03%, outperforming the benchmark SPY, which returned +15.44% annual.
Since Apr 29, 2004, CYTK has had an average annual return of -1.40%, underperforming the benchmark SPY, which returned +11.04% annual.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| +11.28% | +35.07% | -43.65% | +82.23% | +0.53% | +119.34% | +95.90% | +67.89% | -22.51% | -32.91% | +16.16% | +30.64% |
| 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |
| +23.18% | +64.15% | -31.21% | -54.08% | -28.17% | +2.09% | -39.75% | -36.76% | +14.38% | -36.19% | -36.34% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -0.56% | -1.53% | +5.93% | -2.95% | +19.99% | -7.88% | +11.28% | ||||||
| 2025 | +5.13% | -6.99% | -12.64% | +6.61% | -27.60% | +6.51% | +13.92% | -6.13% | +55.56% | +15.71% | +7.14% | -6.73% | +35.07% |
| 2024 | -6.42% | -7.54% | -2.94% | -12.54% | -20.89% | +11.69% | +8.91% | -3.27% | -7.50% | -3.40% | +1.69% | -9.29% | -43.65% |
| 2023 | -7.27% | +2.07% | -18.85% | +6.29% | +0.77% | -13.45% | +2.22% | +4.78% | -15.68% | +18.33% | -3.96% | +149.37% | +82.23% |
| 2022 | -27.17% | +6.40% | +4.24% | +8.29% | +0.07% | -1.53% | +7.75% | +25.10% | -8.50% | -9.89% | -2.65% | +7.80% | +0.53% |
| 2021 | -5.35% | -4.76% | +24.19% | +9.39% | -14.20% | -9.34% | +49.93% | +11.10% | +8.41% | -2.32% | +12.67% | +15.86% | +119.34% |
| 2020 | +15.94% | +13.35% | -15.45% | +28.20% | +37.08% | +13.81% | -8.28% | +10.81% | -9.64% | -29.00% | +9.30% | +23.69% | +95.90% |
| 2019 | +11.31% | +2.61% | +12.05% | +9.08% | +17.52% | +8.57% | +8.33% | +15.21% | -18.98% | +2.38% | -17.00% | +9.69% | +67.89% |
| 2018 | +12.80% | -15.76% | -7.11% | +15.30% | +8.50% | -7.83% | -11.41% | +7.49% | +24.69% | -32.06% | +17.46% | -19.66% | -22.51% |
| 2017 | -13.99% | +1.39% | +21.24% | +27.67% | -17.37% | -10.69% | +16.04% | +5.71% | -2.34% | -5.86% | -37.01% | -5.17% | -32.91% |
Drawdown analysis of Cytokinetics (CYTK)
The maximum drawdown for the CYTK was -97.09%, occurring on Oct 10, 2014. Recovery took 2325 trading sessions.
The current CYTK drawdown is -34.56%.
Since Apr 29, 2004 CYTK has experienced the following drawdowns:
- 50% or more: 2 times
- 40% or more: 2 times
- 30% or more: 2 times
- 20% or more: 2 times
- 10% or more: 2 times
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -97.09% | May 5, 2004 | 2627 | Oct 10, 2014 | 2325 | Jan 8, 2024 | 4952 |
| -72.39% | Jan 8, 2024 | 339 | May 15, 2025 | Ongoing | Ongoing | Ongoing |
| -1.52% | May 3, 2004 | 1 | May 4, 2004 | 1 | May 5, 2004 | 2 |